Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Heritage
FDA Approves LURASIDONE HYDROCHLORIDE — Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc. announced FDA approval for its generic LURASIDONE HYDROCHLORIDE tablets, expanding the suppl...

SUN
FDA Approves Unknown Drug — SUN PHARM

SUN PHARM has successfully secured FDA approval for NDA212595, unlocking its potential revenue stream from this strategic pharmaceutical product. This...

Celgene
FDA Approves INREBIC — Celgene Corporation

# FDA Approves Celgene's INREBIC (Fedratinib) for Myelofibrosis Treatment Celgene Corporation has received FDA approval for INREBIC (fedratinib hydro...

AbbVie
FDA Approves RINVOQ — AbbVie Inc.

AbbVie Inc. received final regulatory approval on August 16, 2019, for Upadacitinib, expanding its gastrointestinal pharmacopoeia under the RINVOQ bra...

Unichem
FDA Approves TRAMADOL HYDROCHLORIDE — Unichem Pharmaceuticals (USA), Inc.

# FDA Approves Unichem Pharmaceuticals' Generic Tramadol Hydrochloride Unichem Pharmaceuticals (USA), Inc. received FDA approval for its generic tram...

AiPing
FDA Approves CELECOXIB — AiPing Pharmaceutical, Inc.

# FDA Approves Generic Celecoxib Application for AiPing Pharmaceutical The FDA has approved ANDA208856 for AiPing Pharmaceutical, Inc.'s generic cele...

HIBROW
FDA Approves Unknown Drug — HIBROW HLTHCARE

# FDA Approves New Generic Drug Application for Hibrow Healthcare Hibrow Healthcare has received FDA approval for its abbreviated new drug applicatio...

BAYER
FDA Approves Unknown Drug — BAYER HEALTHCARE

On July 30, 2019, the FDA granted approval for BAYER HEALTHCARE's generic drug NDA212099, a move that is expected to provide cost-effective competitio...

Cordavis
FDA Approves ADALIMUMAB-BWWD — Cordavis Limited

Cordavis Limited announced the FDA approval of adalimumab-bwwd, a biosimilar of a major TNF-alpha inhibitor, allowing for the establishment of a new m...

PFIZER
FDA Approves Unknown Drug — PFIZER INC

Pfizer Inc. received FDA approval for BMS-986165 on July 23, 2019, advancing its potential treatment for metabolic diseases. Market analysts anticipat...

Upsher-Smith
FDA Approves MORPHINE SULFATE — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories, LLC announced the approval of a supplemental New Drug Application for its Morphine Sulfate product, broadening its portfoli...

Leading
FDA Approves FENOFIBRIC ACID — Leading Pharma, LLC

Leading Pharma, LLC received FDA approval for its Fenofibric Acid via ANDA211626, a strategic development that will likely expand generic availability...

Karyopharm
FDA Approves XPOVIO — Karyopharm Therapeutics Inc.

# FDA Approves Karyopharm Therapeutics' XPOVIO (selinexor) for Multiple Myeloma Karyopharm Therapeutics Inc. received FDA approval for XPOVIO (seline...

Advagen
FDA Approves TRAMADOL HYDROCHLORIDE — Advagen Pharma Limited

Advagen Pharma Limited has gained FDA approval for its oral Tramadol Hydrochloride tablets, granting the company entry into the generic market for a w...

Eywa
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Eywa Pharma Inc

Eywa Pharma Inc. received 180-day exclusivity for the ANDA211610 approval of acetaminophen and codeine phosphate oral dosage form on June 27, 2019, si...

Cosette
FDA Approves VYLEESI — Cosette Pharmaceuticals, Inc.

Cosette Pharmaceuticals received FDA approval for VYLEESI (bremelanotide acetate) on June 21, 2019, making it the first and only prescription therapy ...

Mylan
FDA Approves SCOPOLAMINE — Mylan Pharmaceuticals Inc.

Mylan received FDA approval on June 19, 2019, for the generic transdermal formulation of scopolamine, signaling a significant opportunity for market e...

Genentech,
FDA Approves POLIVY — Genentech, Inc.

# FDA Approves Genentech's POLIVY (polatuzumab vedotin) for Intravenous Administration Genentech's FDA approval of POLIVY (polatuzumab vedotin) marks...

Alembic
FDA Approves CARBIDOPA AND LEVODOPA — Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited announced the approval of its Abbreviated New Drug Application for Carbidopa and Levodopa, signaling a strategic expan...

Publix
FDA Approves ARTHRITIS PAIN RELIEVER — Publix Super Markets Inc

Publix Super Markets Inc’s FDA approval of its diclofenac sodium topical preparation on May 16, 2019, further expands the generic threat to big-name b...